# Interlaboratory assessment of candidate reference materials for lentiviral vector copy number and integration site measurements

**Authors:** Hua-Jun He, Zhiyong He, Steven P. Lund, Laure Turner, Yongjun Fan, Yu Qiu, David C. Corney, Boro Dropulic, Rimas Orentas, Oxana Slessareva, Priscilla Welch, Katie Dungca, Ellen Stelloo, Gabrielle Dijksteel, Harma Feitsma, Sana Ahmed-Seghir, Rostyslav Makarenko, Engin Altunlu, Daniëlle Steenmans, Jan Spanholtz, Monica Raimo, Shai Senderovich, Barbara S. Paugh, Chieh-Yuan Li, Benjamin Schroeder, Alexandra S. Whale, Dilek Yener, Carole A. Foy, Shareef Nahas, Feng Tu, Michael Sheldon, Yan Ding, Jennifer Kandell, Uma Lakshmipathy, Jennifer H. McDaniel, Justin M. Zook, Sierra Miller, Samantha Maragh, Simona Patange, Mahir Mohiuddin, Alessandro Tona, Kenneth D. Cole, Sheng Lin-Gibson

PMC · DOI: 10.1016/j.omtm.2025.101472 · 2025-04-21

## TL;DR

This paper assesses candidate reference materials for measuring lentiviral vector copy numbers and integration sites to improve consistency and accuracy in gene therapy safety evaluations.

## Contribution

The study provides consensus values for vector copy numbers and integration sites in NIST candidate reference materials, enabling harmonization of measurement assays.

## Key findings

- Twelve laboratories successfully measured vector copy numbers in five candidate reference materials using qPCR, dPCR, or NGS.
- Consensus values for vector copy numbers and integration sites were achieved across all participants.
- Molecular combing technology was evaluated using fixed clonal cells for potential integration site analysis.

## Abstract

While lentiviral vectors have played a critical role in the emergence of gene-modified cell therapies, safety concerns remain regarding potential insertional mutagenesis. Regulatory authorities strongly recommend risk assessment and management of vector copy numbers (VCNs), integration profiles, and integration sites in the lentivirus-based cell and gene therapy products. However, accurately measuring these parameters remains a significant challenge due to the lack of standardized methodologies and VCN reference materials (RMs). Toward this challenge, we conducted an interlaboratory study on NIST candidate RMs for VCN measurements. The candidate RMs comprise five human genomic DNA samples or fixed cells from clonal Jurkat cell lines with defined VCNs ranging from 0 to 4. All 12 study participants were able to identify the VCN in the five blinded samples using quantitative PCR (qPCR), digital PCR (dPCR), or next generation sequencing (NGS) assays. Consensus value of VCN and integration sites in these candidate RMs were achieved. The fixed clonal VCN cells were also used to evaluate an emerging imaging-based technology called molecular combing. This interlaboratory assessment demonstrated the utility, commutability, and suitability of the NIST VCN candidate RMs for quality assurance and improved confidence in VCN, integration profile, and integration site measurements.

An NIST candidate lentiviral vector copy number (VCN) reference material was assessed by an interlaboratory study. The consensus VCN value could be used for assay harmonization in VCN measurements and consensus integration sites could be used to benchmark and improve the NGS technologies and bioinformatics pipelines.

## Linked entities

- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12229725/full.md

---
Source: https://tomesphere.com/paper/PMC12229725